(Q57569294)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9989717%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

title

Tumour necrosis factor alpha and interleukin 1beta in relapse of Crohn's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9989717%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

0 references

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9989717%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

author name string

S Schreiber

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9989717%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

S Nikolaus

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9989717%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

J Hämling

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9989717%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

I Koop

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9989717%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

B Groessner

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9989717%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

H Lochs

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9989717%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

A Raedler

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9989717%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

language of work or name

English

0 references

publication date

1 February 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9989717%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9989717%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

volume

353

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9989717%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

issue

9151

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9989717%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

page(s)

459-461

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9989717%20AND%20SRC:MED&resulttype=core&format=json

Disease activity courses in a regional cohort of Crohn's disease patients.

12 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903339-X

7 January 2021

Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled, dose-ranging study. Canadian Inflammatory Bowel Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903339-X

7 January 2021

Inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903339-X

7 January 2021

Predictors of acute relapse of Crohn's disease. A laboratory and clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903339-X

7 January 2021

Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903339-X

7 January 2021

A laboratory index for predicting relapse in asymptomatic patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903339-X

7 January 2021

Role of interleukin 1 in inflammatory bowel disease--enhanced production during active disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903339-X

7 January 2021

Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903339-X

7 January 2021

Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903339-X

7 January 2021

Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903339-X

7 January 2021

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903339-X

7 January 2021

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903339-X

7 January 2021

Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903339-X

7 January 2021

On the Kolmogorov-Smirnov Test for Normality with Mean and Variance Unknown

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903339-X

7 January 2021

Intestinal permeability and the prediction of relapse in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903339-X

7 January 2021

Microscopic activity in ulcerative colitis: what does it mean?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903339-X

7 January 2021

Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903339-X

7 January 2021

10.1016/S0140-6736(98)03339-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9989717%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

1 reference